D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor

被引:97
作者
Jarrahian, A [1 ]
Watts, VJ [1 ]
Barker, EL [1 ]
机构
[1] Purdue Univ, Sch Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
关键词
D O I
10.1124/jpet.103.057620
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CB1 cannabinoid (CB1) and D-2 dopamine (D-2) receptors are known to couple to the G protein Galpha(i/o). It has been reported that concurrent activation of D-2 receptors and CB1 receptors, in primary striatal neuronal culture, promotes functional CB1 receptor coupling to Galpha(s) resulting in elevations in intracellular cyclic AMP levels. We now report that in the absence of D-2 receptors, acute activation of CB1 receptors inhibits cyclic AMP accumulation, whereas the presence of D-2 receptors promotes CB1-stimulated cAMP accumulation, presumably through Galpha(s). This Galpha(s) subunit switching was not prevented by pertussis toxin treatment and occurred in the presence and absence of D-2 receptor activation. Thus, coexpression of the D-2 receptor with the CB1 receptor was sufficient to switch the coupling of the CB1 receptors from Galpha(i/o) to Galpha(s). Persistent activation of D-2 receptors resulted in heterologous sensitization of adenylate cyclase to subsequent stimulation by forskolin, whereas the persistent activation of CB1 receptors did not. Additional studies in human embryonic kidney cells cotransfected with D-2 and CB1 receptors revealed that persistent activation (18 h) of D-2 receptors induced a switch of CB1 receptor coupling from Galpha(s) to Galpha(i/o). This D-2 receptor-induced effect allowed for CB1 receptor-mediated inhibition of cyclic AMP accumulation. The present studies suggest D-2 receptors may have a significant modulatory role in determining the G protein coupling specificity of CB1 receptors.
引用
收藏
页码:880 / 886
页数:7
相关论文
共 29 条
[1]   Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gsα [J].
Ammer, H ;
Schulz, R .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :993-999
[2]   Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of Gi/o-coupled receptors:: Changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation [J].
Bayewitch, ML ;
Nevo, I ;
Avidor-Reiss, T ;
Levy, R ;
Simonds, WF ;
Vogel, Z .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :820-825
[3]  
Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884
[4]   CANNABINOID LIGAND-RECEPTOR SIGNALING IN THE MOUSE UTERUS [J].
DAS, SK ;
PARIA, BC ;
CHAKRABORTY, I ;
DEY, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4332-4336
[5]  
Felder CC, 1998, J PHARMACOL EXP THER, V284, P291
[6]   Dopamine activation of endogenous cannabinoid signaling in dorsal striatum [J].
Giuffrida, A ;
Parsons, LH ;
Kerr, TM ;
de Fonseca, FR ;
Navarro, M ;
Piomelli, D .
NATURE NEUROSCIENCE, 1999, 2 (04) :358-363
[7]   Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a G(s) linkage to the CB1 receptor [J].
Glass, M ;
Felder, CC .
JOURNAL OF NEUROSCIENCE, 1997, 17 (14) :5327-5333
[8]   CANNABINOID RECEPTOR LOCALIZATION IN BRAIN [J].
HERKENHAM, M ;
LYNN, AB ;
LITTLE, MD ;
JOHNSON, MR ;
MELVIN, LS ;
DECOSTA, BR ;
RICE, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1932-1936
[9]  
HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pa.35.040195.003135
[10]   INCREASED FORSKOLIN BINDING IN THE LEFT PARAHIPPOCAMPAL GYRUS AND CA1 REGION IN POST-MORTEM SCHIZOPHRENIC BRAIN DETERMINED BY QUANTITATIVE AUTORADIOGRAPHY [J].
KERWIN, RW ;
BEATS, BC .
NEUROSCIENCE LETTERS, 1990, 118 (02) :164-168